Reapplix 3C Patch Retrospective Analysis
Reapplix
Reapplix specializes in the biological treatment and healing of chronic wounds. The patented 3CPatch® System is an innovative, evidence-based biological wound therapy made entirely from the patient’s own blood – nothing else. This Circle aggregates retrospective, real-world data focused on the application and outcome of the 3CPatch® System.
Observational
Access and contribute towards a growing repository of real-world data focused on 3CPatch® administration protocols and their outcomes, measured in wound size changes, rate of healing, and patient-reported satisfaction.
Wound Assessment
Private Circle
Reapplix 3C Patch Retrospective Analysis
Reapplix specializes in the biological treatment and healing of chronic wounds. The patented 3CPatch® System is an innovative, evidence-based biological wound therapy made entirely from the patient’s own blood – nothing else. This Circle aggregates retrospective, real-world data focused on the application and outcome of the 3CPatch® System.
Wound Assessment
Access and contribute towards a growing repository of real-world data focused on 3CPatch® administration protocols and their outcomes, measured in wound size changes, rate of healing, and patient-reported satisfaction.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private Circle
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.